Oncolytics Biotech updates GOBLET study data and PanCAN grant payment
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
01:32:10 PM UTC
SquawkNews
Completion of enrollment earlier this year and expected final PanCAN grant payment this quarter mark successful completion of a key phase of Cohort 5Final Cohort 4 results expected in Q4 2026; initial Cohort 5 results expected in the first half of 2027The Company will use the clinical data to focus…
01:33:09 PM UTC
SquawkNews
Oncolytics Biotech Inc. said final GOBLET Cohort 4 results are expected in Q4 2026 and initial Cohort 5 results in H1 2027; the company expects the final PanCAN grant payment later this quarter.Material DetailsContext by AI AnalystThis is a mid-cycle clinical update setting catalysts for GI oncolog…